| Product Code: ETC9973883 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Poliomyelitis Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Poliomyelitis Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Poliomyelitis Market - Industry Life Cycle |
3.4 United States (US) Poliomyelitis Market - Porter's Five Forces |
3.5 United States (US) Poliomyelitis Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Poliomyelitis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 United States (US) Poliomyelitis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 United States (US) Poliomyelitis Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 United States (US) Poliomyelitis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Poliomyelitis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Government initiatives and vaccination programs aimed at eradicating poliomyelitis |
4.2.2 Increasing awareness about the importance of vaccination and disease prevention |
4.2.3 Technological advancements in vaccine development and distribution |
4.3 Market Restraints |
4.3.1 Vaccine hesitancy and misinformation leading to lower vaccination rates |
4.3.2 High cost of vaccination programs and treatments for poliomyelitis |
4.3.3 Limited access to healthcare facilities in certain regions |
5 United States (US) Poliomyelitis Market Trends |
6 United States (US) Poliomyelitis Market, By Types |
6.1 United States (US) Poliomyelitis Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Poliomyelitis Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Poliomyelitis Market Revenues & Volume, By Nonparalytic Polio, 2021- 2031F |
6.1.4 United States (US) Poliomyelitis Market Revenues & Volume, By Nonparalytic Polio, 2021- 2031F |
6.1.5 United States (US) Poliomyelitis Market Revenues & Volume, By Post-Polio Syndrome, 2021- 2031F |
6.2 United States (US) Poliomyelitis Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Poliomyelitis Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 United States (US) Poliomyelitis Market Revenues & Volume, By Vaccination, 2021- 2031F |
6.2.4 United States (US) Poliomyelitis Market Revenues & Volume, By Supportive Treatments, 2021- 2031F |
6.2.5 United States (US) Poliomyelitis Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Poliomyelitis Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Poliomyelitis Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 United States (US) Poliomyelitis Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 United States (US) Poliomyelitis Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Poliomyelitis Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Poliomyelitis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United States (US) Poliomyelitis Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 United States (US) Poliomyelitis Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 United States (US) Poliomyelitis Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) Poliomyelitis Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Poliomyelitis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 United States (US) Poliomyelitis Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 United States (US) Poliomyelitis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 United States (US) Poliomyelitis Market Import-Export Trade Statistics |
7.1 United States (US) Poliomyelitis Market Export to Major Countries |
7.2 United States (US) Poliomyelitis Market Imports from Major Countries |
8 United States (US) Poliomyelitis Market Key Performance Indicators |
8.1 Vaccination coverage rates in high-risk areas |
8.2 Number of reported poliomyelitis cases in the United States |
8.3 Funding allocated towards poliomyelitis research and prevention efforts |
9 United States (US) Poliomyelitis Market - Opportunity Assessment |
9.1 United States (US) Poliomyelitis Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Poliomyelitis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 United States (US) Poliomyelitis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 United States (US) Poliomyelitis Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 United States (US) Poliomyelitis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Poliomyelitis Market - Competitive Landscape |
10.1 United States (US) Poliomyelitis Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Poliomyelitis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here